CeNeRx BioPharma Completes $9 Million Financing
-New Funds to Support Advancement of Multiple Novel Programs for CNS Disorders-
RESEARCH TRIANGLE PARK, N.C., June 16 — CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $9 million financing. The financing includes a $5 million credit facility from [...]
